Case-crossover and case-time-control designs in birth defects epidemiology

American Journal of Epidemiology

Volumn 158, Issue 4, 2003, Pages 385-391

  Hernández Díaz, Sonia ^a   Hernán, Miguel A ^b   Meyer, Katie ^b   Werler, Martha M ^a   Mitchell, Allen A ^a  

^a BOSTON UNIVERSITY   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Abnormalities; Case control studies; Pregnancy

Indexed keywords

FOLIC ACID ANTAGONIST;

EPIDEMIOLOGICAL PHENOMENA; PREGNANCY; WOMENS HEALTH;

ARTICLE; BIRTH DEFECT; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; GESTATIONAL AGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; PREGNANCY; COMPARATIVE STUDY; CONGENITAL HEART MALFORMATION; CROSSOVER PROCEDURE; EPIDEMIOLOGY; FEMALE; NEWBORN; RISK; UNITED STATES;

CASE-CONTROL STUDIES; CROSS-OVER STUDIES; EPIDEMIOLOGIC METHODS; FEMALE; FOLIC ACID ANTAGONISTS; HEART DEFECTS, CONGENITAL; HUMANS; INFANT, NEWBORN; ODDS RATIO; PREGNANCY; UNITED STATES;

EID: 0043286838     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwg144     Document Type: Article

References (18)

1. Hernández-Díaz S, Werler MM, Walker AM, et al. Folic acid antagonists during pregnancy and risk of specific birth defects. N Engl J Med 2000;343:1608-14.
2. Shaw GM, O'Malley CD, Wasserman CR, et al. Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring. Am J Med Genet 1995;59:536-45.
3. Czeizel AE. Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet 1996;62:179-83.
4. Botto LD, Khoury MJ, Mulinare J, et al. Periconceptional multivitamin use and occurrence of conotruncal heart defects: results from a population-based, case-control study. Pediatrics 1996;98:911-17.
5. Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol 1991;133:144-53.
6. Suissa S. The case-time-control design. Epidemiology 1995;6: 248-53.
7. Mitchell AA, Rosenberg L, Shapiro S, et al. Birth defects related to Bendectin use in pregnancy. I. Oral clefts and cardiac defects. JAMA 1981;245:2311-14.
8. Moore K, Persaud T. The developing human: clinically oriented embryology. Philadelphia, PA: WB Saunders Company, 1998.
9. Hernán M, Hernández-Díaz S, Werler MM, et al. Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am J Epidemiol 2002;155:176-84.
10. Walker AM. Observation and inference. An introduction to the methods of epidemiology. Newton Lower Falls, MA: Epidemiology Resources, Inc, 1991.
11. Rothman KJ, Greenland S. Modern epidemiology. 2nd ed. Philadelphia, PA: Lippincott-Raven Publishers, 1998.
12. Mitchell AA. Special considerations in studies of drug-induced birth defects. In: Strom BL, ed. Pharmacoepidemiology. New York, NY: John Wiley & Sons, Inc, 2000:595-608.
13. Maclure M, Mittleman MA. Should we use a case-crossover design? Annu Rev Public Health 2000;21:193-221.
14. Navidi W. Bidirectional case-crossover designs for exposures with time trends. Biometrics 1998;54:596-605.
15. Greenland S. Confounding and exposure trends in case-crossover and case-time-control designs. Epidemiology 1996;7:231-9.
16. Suissa S. The case-time-control design: further assumptions and conditions. Epidemiology 1998;9:441-5.
17. Greenland S. The effect of misclassification in matched-pair case-control studies. Am J Epidemiol 1982;116:402-6.
18. Mittleman MA, Maclure M, Robins JM. Control sampling strategies for case-crossover studies: an assessment of relative efficiency. Am J Epidemiol 1995;142:91-8.